Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting
Open Access
- 8 February 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 21 (4), 706-713
- https://doi.org/10.1038/sj.leu.2404535
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspectsLeukemia, 2003
- T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysisLeukemia, 2002
- Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALLBlood, 2002
- Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemiaBest Practice & Research Clinical Haematology, 2002
- Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemiaLeukemia, 2001
- Minimal residual disease in leukaemia patientsThe Lancet Oncology, 2001
- Suitable DNA isolation method for the detection of minimal residual disease by PCR techniquesLeukemia, 1999
- Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemiaLeukemia, 1999
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998
- Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic LeukemiaThe New England Journal of Medicine, 1998